SS Innovations International (NASDAQ: SSII) announced it has been named the winner of the Outstanding Company category at the 2026 Surgical Robotics Industry Awards, which recognizes a company demonstrating excellence in innovation, commercial success, industry leadership and positive societal impact. The award reflects the growing adoption of its SSi Mantra surgical robotic system, which the company believes is gaining traction for its advanced technology, user-friendly design, training capabilities and cost efficiency.
As of June 22, 2026, SS Innovations reported that 11,719 multi-specialty procedures had been performed using the SSi Mantra system, including 612 cardiac procedures, 175 telesurgeries and 212 pediatric surgeries. The company also said approximately 2,100 physicians have been trained on the platform, which has been used for more than 170 procedure types and has received regulatory approval in 14 countries. This milestone underscores the system's expanding global footprint and its potential to democratize access to robotic surgery.
The SSi Mantra system is designed to address key barriers in surgical robotics, such as high costs and steep learning curves. By offering a more affordable and user-friendly alternative, SS Innovations aims to make robotic surgery accessible to a broader patient population, particularly in underserved regions. The company's focus on cost efficiency and comprehensive training programs has likely contributed to its rapid adoption, as evidenced by the high number of trained physicians and diverse procedure types.
The award also highlights SS Innovations' leadership in telesurgery, with 175 procedures conducted remotely, showcasing the system's potential to expand surgical access in remote areas. Additionally, the inclusion of 212 pediatric surgeries demonstrates the system's versatility across different patient demographics. For more details on the award, visit the full press release at https://ibn.fm/XWdRe.
SS Innovations International, Inc. develops innovative surgical robotic technologies with a vision to make the benefits of robotic surgery affordable and accessible to a larger segment of the global population. The company's product range includes its proprietary SSi Mantra surgical robotic system and its comprehensive suite of SSi Mudra surgical instruments, which support a variety of surgical robotic procedures including cardiac surgery. An American company headquartered in India, SS Innovations plans to expand the global presence of its technologically advanced, user-friendly, and cost-effective surgical robotic solutions. More information is available at the company's website: ssinnovations.com.
